Boehringer Ingelheim International Reports - Industry Research
Reports Featuring Boehringer Ingelheim International
_Market_Major_Players_Logo.webp){kind=logo}
Pharmaceutical CMO Market
The Pharmaceutical CMO Market size is estimated at USD 171.18 billion in 2024, and is expected to reach USD 230.38 billion by 2029, growing at a CAGR of 6.12% during the forecast period (2024-2029).
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
The Pharmaceutical Contract Development and Manufacturing Organization Market size is estimated at USD 238.47 billion in 2024, and is expected to reach USD 330.36 billion by 2029, growing at a CAGR of 6.74% during the forecast period (2024-2029).
Europe Pharmaceutical Contract Manufacturing Market
Europe Pharmaceutical Contract Manufacturing Market is expected to grow at a CAGR of 5.71% in the forecast period.
Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market
The Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size is estimated at USD 55.15 billion in 2024, and is expected to reach USD 83.85 billion by 2029, growing at a CAGR of 8.74% during the forecast period (2024-2029).
Latin America Pharmaceutical Contract Manufacturing Organization Market
The Latin America pharmaceutical contract manufacturing organization market is expected to register a CAGR of 3.3% during the forecast period 2020 - 2025.
Other Reports Covering Boehringer Ingelheim International
Contract Packaging
- Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market
- Biologics CDMO Market
- Europe Pharmaceutical Contract Manufacturing Market
- Latin America Pharmaceutical Contract Manufacturing Organization Market
- NA Pharmaceutical CMO Market
- Pharmaceutical CMO Market
- Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
- US Pharmaceutical CMO Market
